Immunitas Therapeutics

Immunitas Therapeutics is a single cell genomics-based drug discovery company. The company employs a single cell genomics platform to dissect the biology of immune cells in human tumors, thereby advancing discoveries directly from the bench into meaningful clinical improvements. The team innovates around each step of the drug development process, first identifying novel targets, then designing therapeutic strategies, and developing key biomarkers to guide the selection of patients who may benefit from new drugs.